Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests as well as drug delivery in the field of prevention, detection and treatment of infectious diseases and oncology. Novosanis is a Belgian company endorsed on multiple occasions nationally and internationally for its solutions and is ISO13485 certified. Novosanis prospers in user-friendly and clever medical devices meeting all regulatory and quality requirements for self-sampling that improve accuracy and standardization while making handling easier, more consistent and more comfortable for the user. Our sampling solution, Colli-Pee™ is a patented sampling device suited for standardized and guaranteed collection of first-void urine (first 20ml of the urine flow) allowing improved detection of infectious diseases as well as early stage cancer. Colli-Pee™ is in a commercial stage. It is CE-marked and FDA listed. More information on www.novosanis.com of contact us for all your inquiries welcome@novosanis.com Follow us on Twitter: @Novosanis
Looking for a particular Novosanis employee's phone or email?
The Novosanis annual revenue was $6 million in 2026.
3 people are employed at Novosanis.
The NAICS codes for Novosanis are [325413, 3254, 32, 325, 32541].
The SIC codes for Novosanis are [283, 28].